An invalid vocabulary is selected. Please change it in the options.
Title Creditssort descending Start date - Expiration date
Individualized Multidisciplinary CLL/SLL Care: Practical Application of Guidelines and Emerging Data 1.00 02/09/2024 - 12:00am to 02/09/2025 - 12:00am
NCCN Guidelines® Insights - Breast Cancer, Version 4.2023 1.00 06/10/2023 - 12:00am to 06/10/2024 - 12:00am
Archived Monthly Oncology Tumor Boards: Uveal Melanoma: Treatment of Metastatic Disease 1.00 04/17/2023 - 12:00am to 04/17/2024 - 12:00am
Monthly Oncology Tumor Boards: Management of Pheochromocytoma and Paraganglioma 1.00 06/29/2023 - 12:00am to 07/21/2024 - 12:00am
Monthly Oncology Tumor Boards: Systemic Therapy for Metastatic Prostate Cancer 1.00 02/13/2024 - 12:00am to 07/07/2024 - 12:00am
Neoadjuvant/Adjuvant Treatment for Breast Cancer with SABCS Updates 1.25 03/15/2024 - 12:00am to 03/15/2025 - 12:00am
Locoregional Management of Breast Cancer with SABCS Updates 1.25 03/15/2024 - 12:00am to 03/15/2025 - 12:00am
Advances in the Management of Metastatic Castration-Resistant Prostate Cancer: Expert Guidance and Resources for the Interdisciplinary Team 1.25 12/21/2023 - 12:00am to 12/21/2024 - 12:00am
What Drives Reimbursement for Biomarker Testing? 1.25 06/15/2023 - 12:00am to 06/15/2024 - 12:00am
The Evolving Landscape in CLL/SLL: Best Practice Clinical Applications of Current Evidence and New Guideline Recommendations 1.75 07/21/2023 - 12:00am to 07/21/2024 - 12:00am
Advances in Hepatocellular and Biliary Tract Cancers Impacting Patient Outcomes 1.75 07/21/2023 - 12:00am to 07/21/2024 - 12:00am
Clinical Considerations in Renal Cell Carcinoma: Current Evidence, Guideline Recommendations, and a View to the Future 1.75 07/21/2023 - 12:00am to 07/21/2024 - 12:00am
Unlocking the Potential of Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC: The Role of Checkpoint Inhibitors 1.75 08/09/2023 - 12:00am to 08/09/2024 - 12:00am
Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 2.00 12/21/2023 - 12:00am to 12/21/2024 - 12:00am

Pages